Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 5/20 | 0.53 |
| ▸ | TACR1 | P25103 | 2/20 | 0.53 |
| ▸ | CTRB1 | P17538 | 2/20 | 0.52 |
| ▸ | CTSS | P25774 | 3/20 | 0.52 |
| ▸ | CTSL | P07711 | 2/20 | 0.52 |
| ▸ | CTSB | P07858 | 2/20 | 0.52 |
| ▸ | IDO1 | P14902 | 1/20 | 0.52 |
| ▸ | CASP1 | P29466 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.51 |
| ▸ | KYNU | Q16719 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16862505 | 1.00 | CTSK (0.53) | CTSKTACR1CTRB1CTSSCTSL | |
| SCHEMBL18857019 | 0.92 | CTSK (0.52) | CTSKTACR1CTSSCTSLCTSB | |
| SCHEMBL419572 | 0.92 | KYNU (0.60) | CTSKTACR1CTRB1CTSSCTSL | |
| SCHEMBL13244808 | 0.92 | KYNU (0.60) | CTSKTACR1CTRB1CTSSCTSL | |
| SCHEMBL4425694 | 0.91 | PPARA (0.54) | CTSKTACR1CTRB1CTSSCTSL | |
| SCHEMBL8299708 | 0.91 | PPARA (0.54) | CTSKTACR1CTRB1CTSSCTSL | |
| SCHEMBL15381002 | 0.89 | ALDH1A1 (0.58) | CTSKTACR1CTRB1CTSSCTSL | |
| SCHEMBL25636446 | 0.89 | ALDH1A1 (0.58) | CTSKTACR1CTRB1CTSSCTSL | |
| SCHEMBL7365937 | 0.87 | CTSK (0.54) | CTSKCTSSCTSLCTSBALDH1A1 | |
| SCHEMBL254236 | 0.87 | CTSL (0.55) | CTSKCTSSCTSLCTSBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3909962-B1 | METHOD OF PRODUCING L-GLUFOSINATE | CJ CHEILJEDANG CORP (KR) | 2025-05-21 | — | — | EP | disclosed |
| CN-116327974-A | Antibody-drug-conjugates (ADCs) with enzymatically cleavable groups | 拜耳制药股份公司 | 2023-06-27 | — | — | CN | disclosed |
| EP-3558388-A1 | ANTIBODY DRUG CONJUGATES (ADCS) HAVING ENZYMATICALLY CLEAVABLE GROUPS | Bayer Pharma Aktiengesellschaft (DE) | 2019-10-30 | — | — | EP | disclosed |
| EP-3558386-A1 | PRODRUGS OF CYTOTOXIC ACTIVE AGENTS HAVING ENZYMATICALLY CLEAVABLE GROUPS | Bayer Aktiengesellschaft (DE) | 2019-10-30 | — | — | EP | disclosed |
| CN-107921288-A | The targeting conjugate of KSP inhibitor | 拜耳医药股份有限公司 | 2018-04-17 | — | — | CN | disclosed |
| CN-107921145-A | The antibody drug conjugate of KSP inhibitor and anti-TWEAKR antibody（ADC） | 拜耳医药股份有限公司 | 2018-04-17 | — | — | CN | disclosed |
| WO-2017165416-A1 | PROTECTED DERIVATIVES OF 2-AMINO-4-PHOSPHOBUTANOIC ACID | AGENUS INC. (US) | 2017-09-28 | — | — | WO | disclosed |
| CN-106163568-A | Antibody drug conjugates (ADC) containing spindle kinesin (KSP) | 拜耳制药股份公司 | 2016-11-23 | — | — | CN | disclosed |
| US-7662960-B2 | Beta-strand mimetics and method relating thereto | CHOONGWAE PHARMA CORPORATION (KR) | 2010-02-16 | — | — | US | disclosed |
| US-7662960-B2 | Beta-strand mimetics and method relating thereto | CHOONGWAE PHARMA CORPORATION (KR) | 2010-02-16 | — | — | US | disclosed |
| EP-0329606-A2 | Antibiotics from myxocuccos | CIBA-GEIGY AG (CH) | 1989-08-23 | — | — | EP | disclosed |